Discussing vaccines with Johnson & Johnson CEO Alex Gorsky
Published
Johnson & Johnson’s coronavirus vaccine will be a critical option for patients around the world and is the only vaccine candidate with a one-shot regimen. Washington Post columnist David Ignatius interviews the company’s chief executive on the vaccine’s potential and what lies ahead.
Full Article